載入...
Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
Soft tissue sarcomas (STS) are heterogeneous rare malignancies comprising ~1% of all solid cancers in adults and including more than 70 histological and molecular subtypes with different pathological and clinical development characteristics. Over the last two decades, the increased knowledge of the...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7174622/ https://ncbi.nlm.nih.gov/pubmed/32351891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00509 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|